Zodasiran
Zodasiran is a siRNA targeted to ANGPTL3 in the liver.
Product Specifications
CAS Number
2232918-66-8
Product Name Alternative
ARO-ANG3
UNSPSC
12352208
Target
ANGPTL
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Smiles
[Zodasiran]
Molecular Formula
C491H646F13N162O309P43S7
Molecular Weight
15564.70
References & Citations
[1]Rosenson RS, Gaudet D, Hegele RA, et al. Zodasiran, an RNAi Therapeutic targeted to ANGPTL3, for Mixed Hyperlipidemia. N Engl J Med. 2024;391 (10) :913-925.|[2]Kamrul-Hasan ABM, Dutta D, Nagendra L, Mondal S, Bhattacharya S, Kalra S. Safety and Efficacy of the Novel RNA Interference Therapies for Hypertriglyceridemia and Mixed Hyperlipidemia Management: A Systematic Review and Meta-analysis. Endocr Pract. 2024;30 (11) :1103-1112.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
Phase 3
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
DXC58792-01 50 mg
[4- (2-Fluorophenyl) -1,3-thiazol-2-yl]methanamine dihydrochloride
Sign In for Pricing
View Details